Sign In
Buy SAGE
$8.68
+0 (+0%)
At Close: Oct 30, 2025
NEW YORK, Sept. 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sage Therapeutics, Inc. (NASDAQ: SAGE) between April 12, 2021 a
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact Levi & Korsinsky about pending Class Action - SAGE
05:00pm, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE) and certain
Sage Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors Are Invited To Assist The Schall Law Firm
11:00am, Friday, 13'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sage Therapeutics, Inc. ("Sa
Investors Who Lost Money on Sage Therapeutics, Inc. (SAGE) Should Contact Levi & Korsinsky About Pending Class Action - SAGE
10:00am, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08:30am, Friday, 13'th Sep 2024
LOS ANGELES , Sept. 13, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sage Therapeutics, Inc. ("Sage" o
Shareholders of Sage Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - SAGE
07:15am, Friday, 13'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
NEW YORK CITY, NY / ACCESSWIRE / September 13, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sage T
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact Levi & Korsinsky about pending Class Action - SAGE
05:45am, Friday, 13'th Sep 2024
NEW YORK , Sept. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sage Therapeutics, Inc. ("Sage Therapeutics" or the "Company") (NASDAQ: SAGE) of a class action securities lawsu
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Sage Therapeutics, Inc. (“Sage” or the “C
Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact Levi & Korsinsky about pending Class Action - SAGE
11:25am, Thursday, 12'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
